Return to homepagePandemic Pact

Testing antigens against COVID 19

Grant number: RTECD2002

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $5,842.48

  • Funder

    Callaghan Innovation

  • Principal Investigator

    N/A

  • Research Location

    New Zealand

  • Lead Research Institution

    Ruakura Technologies Limited

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract